Glonefro is the solution for dogs and cats with kidney problems. Glonefro improves kidney function, increases the kidney's immune response and increases the animal's survival time.
Kidney disease is highly prevalent in dogs and cats.
Regardless of its etiology, one of the objectives of therapy is to reduce uremic toxins in the blood.
The intestinal mucosa allows the passage of small molecules (such as urea and creatinine) between the blood and the intestine.
Additionally, not only does kidney disease promote changes in the intestinal microbiota through an increase in uremic toxins, intestinal dysbiosis also contributes to increasing the level of these toxins in the blood.
Glonefro is composed of an association of nitrogen-consuming bacteria, prebiotics and phosphorus chelators. This formula proved to be extremely effective in reducing serum levels of urea, creatinine and phosphorus.
Administration of Glonefro allows:
1 - Enteric dialysis
2 - Improve intestinal function
3 – Reduces inflammation
Dogs and cats with kidney changes to improve serum levels of urea, creatinine and phosphorus, preventing the progression of kidney disease and improving quality and average life expectancy
Main actions:
- Decrease in nitrogen compounds in the blood (BUN, CREA)
- Decreased phosphorus in the blood
- Decreased oxidative stress and pro-inflammatory reactions
- Improved kidney function
- Increases renal immune response
- Increased animal survival time
- Stimulation of erythrocyte synthesis
Complementary food, in capsules, indicated for dogs and cats with kidney disorders, improving serum levels of urea, creatinine and phosphorus.
Complementary food, in capsules, indicated for dogs and cats with kidney disorders, improving serum levels of urea, creatinine and phosphorus.
Glonefro is the solution for dogs and cats with kidney problems. Glonefro improves kidney function, increases the kidney's immune response and increases the animal's survival time.
Kidney disease is highly prevalent in dogs and cats.
Regardless of its etiology, one of the objectives of therapy is to reduce uremic toxins in the blood.
The intestinal mucosa allows the passage of small molecules (such as urea and creatinine) between the blood and the intestine.
Additionally, not only does kidney disease promote changes in the intestinal microbiota through an increase in uremic toxins, intestinal dysbiosis also contributes to increasing the level of these toxins in the blood.
Glonefro is composed of an association of nitrogen-consuming bacteria, prebiotics and phosphorus chelators. This formula proved to be extremely effective in reducing serum levels of urea, creatinine and phosphorus.
Administration of Glonefro allows:
1 - Enteric dialysis
2 - Improve intestinal function
3 – Reduces inflammation
Dogs and cats with kidney changes to improve serum levels of urea, creatinine and phosphorus, preventing the progression of kidney disease and improving quality and average life expectancy
Main actions:
- Decrease in nitrogen compounds in the blood (BUN, CREA)
- Decreased phosphorus in the blood
- Decreased oxidative stress and pro-inflammatory reactions
- Improved kidney function
- Increases renal immune response
- Increased animal survival time
- Stimulation of erythrocyte synthesis